Microenvironmental Networks Promote Tumor Heterogeneity and Enrich for Metastatic Cancer Stem-like Cells in Luminal-A Breast Tumor Cells
Overview
Affiliations
The roles of the tumor microenvironment (TME) in generating intra-tumoral diversity within each specific breast cancer subtype are far from being fully elucidated. In this study, we exposed Luminal-A breast cancer cells in culture to combined "TME Stimulation", representing three typical arms of the breast TME: hormonal (estrogen), inflammatory (tumor necrosis factor α) and growth-promoting (epidermal growth factor). In addition to enriching the tumor cell population with CD44+/β1+ cells (as we previously published), TME Stimulation selected for CD44+/CD24low/- stem-like cells, that were further enriched by doxorubicin treatment and demonstrated high plasticity in vitro and in vivo. Knock-down experiments revealed that CD44 and Zeb1 regulated CD24 and β1 expression and controlled differently cell spreading and formation of cellular protrusions. TME-enriched CD44+/CD24low/- stem-like cells promoted dissemination to bones and lymph nodes, whereas CD44+/β1+ cells had a low metastatic potential. Mixed co-injections of TME-enriched CD44+/CD24low/- and CD44+/β1+ sub-populations generated metastases populated mostly by CD44+/CD24low/--derived cells. Thus, combined activities of several TME factors select for CD44+/CD24low/- stem-like cells that dictate the metastatic phenotype of Luminal-A breast tumor cells, suggesting that therapeutic modalities targeting the TME could be introduced as a potential strategy of inhibiting the detrimental stem-like sub-population in this disease subtype.
Ben-Yaakov H, Meshel T, Pasmanik-Chor M, Korner C, Ben-Baruch A Cancers (Basel). 2023; 15(8).
PMID: 37190183 PMC: 10137120. DOI: 10.3390/cancers15082255.
Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy.
Ben-Baruch A Front Immunol. 2022; 13:903679.
PMID: 35663982 PMC: 9157545. DOI: 10.3389/fimmu.2022.903679.
Cancer Stem Cells: An Ever-Hiding Foe.
Wilczynski J Exp Suppl. 2022; 113:219-251.
PMID: 35165866 DOI: 10.1007/978-3-030-91311-3_8.
Cancer stem cells: a major culprit of intra-tumor heterogeneity.
Naz F, Shi M, Sajid S, Yang Z, Yu C Am J Cancer Res. 2022; 11(12):5782-5811.
PMID: 35018226 PMC: 8727794.
Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy.
Baram T, Rubinstein-Achiasaf L, Ben-Yaakov H, Ben-Baruch A Front Oncol. 2021; 10:614468.
PMID: 33585241 PMC: 7873936. DOI: 10.3389/fonc.2020.614468.